miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling-Reference-Cited by-同舟云学术

miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

Published:2011-05-16 Issue:22 Volume:108 Page:9232-9237
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Davalos A.,Goedeke L.,Smibert P.,Ramirez C. M.,Warrier N. P.,Andreo U.,Cirera-Salinas D.,Rayner K.,Suresh U.,Pastor-Pareja J. C.,Esplugues E.,Fisher E. A.,Penalva L. O. F.,Moore K. J.,Suarez Y.,Lai E. C.,Fernandez-Hernando C.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference35 articles.

1. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation

2. Atherosclerosis

3. Inflammation and metabolic disorders

4. Atherosclerosis

5. The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor

Cited by 585 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism;Acta Pharmaceutica Sinica B;2024-09

2. The Interplay Between Cytokines and MicroRNAs to Regulate Metabolic Disorders;Journal of Interferon & Cytokine Research;2024-08-01

3. Liver microRNA transcriptome reveals miR-182 as link between type 2 diabetes and fatty liver disease in obesity;eLife;2024-07-22

4. Metabolic dysfunction−associated liver disease and diabetes: Matrix remodeling, fibrosis, and therapeutic implications;Annals of the New York Academy of Sciences;2024-07-12

5. The ability of microRNAs to regulate the immune response in ischemia/reperfusion inflammatory pathways;Genes & Immunity;2024-06-22